Use of 5-fluorocytosine in patients with impaired renal function.

Autor: Dawborn JK, Page MD, Schiavone DJ
Jazyk: angličtina
Zdroj: British medical journal [Br Med J] 1973 Nov 17; Vol. 4 (5889), pp. 382-4.
DOI: 10.1136/bmj.4.5889.382
Abstrakt: The plasma level and elimination of 5-fluorocytosine (5-FC) was measured in normal subjects and patients with impaired renal function. Prolongation of the half-life of the drug in renal failure has been confirmed. Renal clearance of 5-FC was about 75% of the creatinine clearance and a corresponding modification of drug dosage should be made in patients with renal insufficiency.
Databáze: MEDLINE